Le Large, T. Y. S., El Hassouni, B., Funel, N., Kok, B., Piersma, S. R., Pham, T. V., . . . Giovannetti, E. (2019). Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment. Ther Adv Med Oncol.
Citación estilo ChicagoLe Large, Tessa Ya Sung, et al. "Proteomic Analysis of Gemcitabine-resistant Pancreatic Cancer Cells Reveals That Microtubule-associated Protein 2 Upregulation Associates With Taxane Treatment." Ther Adv Med Oncol 2019.
Cita MLALe Large, Tessa Ya Sung, et al. "Proteomic Analysis of Gemcitabine-resistant Pancreatic Cancer Cells Reveals That Microtubule-associated Protein 2 Upregulation Associates With Taxane Treatment." Ther Adv Med Oncol 2019.